SCHEMBL10568241

SCHEMBL10568241

CCCCCCCCCCCCCCCCCCNC(=O)OC[C@@]1(C)CC[C@@](C)(CO)O1

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.46
ACHE P22303 14/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10544589 1.00 EPHX1 (0.46) EPHX1ACHE
SCHEMBL10544582 1.00 EPHX1 (0.46) EPHX1ACHE
SCHEMBL10569695 1.00 EPHX1 (0.46) EPHX1ACHE
SCHEMBL10569694 1.00 EPHX1 (0.46) EPHX1ACHE
SCHEMBL10541278 0.88 EPHX1 (0.45) EPHX1ACHE
SCHEMBL10546427 0.79
SCHEMBL10546439 0.79
SCHEMBL8887825 0.77 EPHX1 (0.47) EPHX1ACHE
SCHEMBL10542960 0.77 HPGD (0.45)
SCHEMBL10544882 0.77 TLR2 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4868319-A Process for the preparation of monoalkylcarbamate group-containing compounds SANDOZ PHARM. CORP. (US) 1989-09-19 US disclosed